addenbrookes Hospital
Cambridge, United Kingdom
NCT Number: NCT02341313
Low blood sugar levels are common in babies after birth. This may be normal as babies can use other sources of energy. However if a baby does not produce these fuels the brain can be starved of energy and be damaged. Measurement of these fuels is not done as part of clinical practice in the newborn. The investigators aim to see whether at the same time as taking the blood sugar level from a heel prick these fuels can be measured in a small drop of blood. At the same time as blood needs to be taken for clinical reasons the study team will to take a drop of blood from 50 babies to see how good the point of care (POC) meters are compared to the laboratory at measuring these fuels. If accurate these POC meters could identifying those at risk from brain damage as well as prevent separation of mothers and babies who are establishing breast feeding.
Looking for future studies?
Notify MeUp to 1 month
All sexes
Observational
Cambridge, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Time frame: Neonatal period up to 28 days of age
Kathryn Beardsall
Other
Feasibility of the Use of Point of Care Technology to Measure Ketone and Lactate Levels in the Newborn at Risk From Hypoglycaemia Due to Impaired Perinatal Counter Regulation
Acronym: POCKET
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07015970
Autoimmune Diseases, Diabetes Mellitus
Caen, France
View Trial DetailsNCT05470842
Diabetes, Diabetes Mellitus
Norwich, Norfolk, United Kingdom
View Trial DetailsNCT01922817
Autoimmune Diseases, Diabetes Mellitus
Dundee, United Kingdom
View Trial DetailsNCT02107326
Autoimmune Diseases, Diabetes Mellitus
Geneva, Canton of Geneva, Switzerland
View Trial Details